ABOUT 3rd_EHTF
> ATTENDEES​
> INVESTORS
> SHOWCASES
> SPONSORS
> SUPPORTERS

20-minute SHowcases

PIXIUM VISION SA
[EPA: ALPIX]

PIXIUM VISION harnesses rapid advances in visual processing, micro-electronics, opto-electronics, neurobiology, and intelligent software algorithms to develop Bionic Vision Systems utilizing its competencies in machine brain interface and artificial intelligence.

These Bionic Vision Systems are aimed at compensating for profound vision loss and improving the independence, mobility and quality of life for patients suffering with retinal degenerative diseases.

https://www.pixium-vision.com

Vivasure Medical Ltd.

Vivasure Medical Limited has developed a novel approach to enable minimally invasive treatment of cardiovascular disease. Our technology is CE marked and will start US clinical work this year, further changing the paradigm for cardiovascular disease.

vivasuremedical.com/

10-minute SHowcases

Alertgy, Inc.

Alertgy is a pioneer in 100% non-invasive continuous blood glucose monitoring technology. Through the use of its patented radio frequency sensor, Alertgy’s DeepGluco wearable device is able to accurately measure blood glucose in real time, up to 3 times per minute. Most importantly, using our proprietary AI algorithm, DeepGluco can provide invaluable, up to the minute life-saving alerts to the users and their designated HCPs. Unlike other CGMs, we eliminate interstitial lag as well as painful and uncomfortable side effects of patches, needles, and implants. The final DeepGluco form factor will be similar to modern smart watches, available to consumers following FDA and CE Mark approvals.

www.alertgy.com/

BAYOOmEd AG

We implement software projects for the pharmaceutical industry and the medical technology sector.
 
Our focus is on the development of medical and healthcare apps as well as medical software and digital health applications (DiGA). According to all valid standards for medical devices we plan, develop and document for national and international customers for more than 10 years.
 
We support you in all product lifecycle phases, taking into account the regulations and requirements of your target market. Whether this is in the EU (MDR), the USA (FDA), Brazil (ANVISA) or other countries – we know the legal regulations and develop according to these specifications.

www.bayoomed.com/en

Omixon Biocomputing Kft.

Omixon is a molecular diagnostics company that markets transplant diagnostic solutions to clinical and research laboratories.

Omixon uses its multidisciplinary competence ranging from bioinformatics, through software engineering to molecular diagnostics to design its products.

Our goal is to enable histocompatibility labs to turn innovative technologies into better transplant outcomes.​

www.omixon.com/

Oxford Endovascular Ltd.

Oxford Endovascular is a spin-out from Oxford University, working to treat brain aneurysms.
 
OxiFlow™️ is a novel, next generation flow-diverter, that diverts blood flow away from intracranial aneurysms at risk of rupture. It places more accurately and safely than existing devices, reducing the risk of adverse events. It conforms better to blood vessels making more patients treatable and has the capability to become the market leading device.
 
Conceived by a world-renowned physician who pioneered the treatment of aneurysms over the last 30 years and an expert in ‘Origami Engineering’, it has patents in Europe, US, China & Japan.  

www.oxfordendovascular.com

Portal Instruments, Inc.

Portal Instruments is a clinical stage, privately funded, medical device company focused on advanced drug delivery and solving the challenge of self-administering biological medicines with a needle-free injection approach.

www.portalinstruments.com/

Surgify Medical Oy

Surgify is a Finnish MedTech company commercializing a next-generation cutting technology for smarter, safer, and simpler bone surgery. This smart technology enables bone and hard tissue cutting without injuries to surrounding soft tissues, such as blood vessels and nerves. Our first product is CE-marked and is in clinical use in Finland. We are in the process of raising a financing round for expanding our commercial activities. Surgical operations involving bone cutting always carry risks and often lead to soft tissue injuries. Most devastating complications are related to head, neck, and spine procedures. Millions of such operations are performed every year and various clinical studies indicate that the risk of soft tissue injury can be as high as 30%. So far, Surgify technology has eliminated all such injuries in preclinical and clinical conditions. Surgify’s novel technology also enables faster surgeries and automatization of procedures involving bone cutting.

https://surgifymedical.com/

5-minute SHowcase

PRAMOMOLECULAR GmbH

PRAMOMOLECULAR, a spin-off of Technische Universität Berlin, uses a proprietary platform technology to downregulate mRNA in vivo in organs - beyond the liver. Initial targets for gene silencing with RNAi are KRAS-dependent cancers and metabolic diseases in the lung, pancreas, and heart.

www.pramomolecular.com/

European Health Tech Startups Presented by EIT Health

.lumen (Dotlumen SRL)

.lumen builds glasses that empower the blind to live a better life.

www.dotlumen.com/

Abtrace Ltd.

Abtrace is a healthtech start-up using machine learning to transform how chronic and long-term health conditions are detected, monitored and treated.

Its unique AI tool can plug-into the Electronic Health Record (EHR) database and identify which tests or treatments a patient with a long-term health condition needs or might benefit from.

The software allows Primary Care clinicians and healthcare assistants to make more informed decisions, automate key elements of disease monitoring, and ensure patients receive consistent, effective care.

www.abtrace.co/

Advosense GmbH

Commited to transforming geriatric care, starting with incontinence management.

www.advosense.com/

AZmed

AZmed was founded with the aim of improving patient care in emergency and radiology departments. The first solution developed, Rayvolve is a computer-aided diagnosis tool able to detect all types of fractures and chest abnormalities on standard x-rays.

azmed.co/

Brain+

Brain+ develops digital theraputics for the detection and treatment of dementia. We work together with leading reasearchers and clnicians in dementia to develop clinically validated software as a medical device products that we expect to be reimbursed by healthcare systems and insurance providers, with first launch targets of Denmark and Germany.

www.brain-plus.com

InCephalo Ltd.

InCephalo - next-generation CNS-cancer drugs.

The company focuses on developing antibodies and other biological treatments for the local treatment of CNS cancers. It has a preclinical candidate for glioblastoma (an aggressive brain tumor), which received EMA orphan designation and is currently establishing a pipeline of new drug candidates.

InCephalo has a proprietary compartment-locked technology, CLock, that allows them to create tailor-made molecules for CNS cancers.

incephalo.com/

Neurocast BV

Neurocast turn everyday daily digital interactions, such as smartphone use, into medically approved outcomes, enabling individual patients' performance monitoring in everyday life. We aim to provide insights into neurodegenerative disorders such as MS, AD and MDD.

neurocast.nl/